跳至主要内容
临床试验/CTRI/2023/07/055054
CTRI/2023/07/055054尚未招募4 期

Effect of neostigmine on attenuation of proinflammatory cytokines secretion when given as an adjunctive therapy in septic shock: A Randomized controlled trial - NI

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients aged above 18 years
  • Patients having clinical features suggestive of septic shock ( Requiring vasopressor support to maintain Mean Arterial Pressure greater than 65 mm Hg)

排除标准

  • 1.Known absolute contraindications against cholinesterase inhibitor such as, myotonic dystrophy, depolarization block by depolarizing muscle relaxant, intoxication by irreversibly acting cholinesterase inhibitors, closed craniocerebral trauma.
  • 2.Known relative contraindications against cholinesterase inhibitors eg bronchial asthma, brady cardia, A-V conduction disturbances. 3.Pregnant and lactating women.
  • 4.Having undergone solid organ transplantation

研究者

相似试验